EP2411031A4 - Méthodes et compositions pour le traitement du cancer - Google Patents

Méthodes et compositions pour le traitement du cancer

Info

Publication number: EP2411031A4
Authority: EP; European Patent Office
Prior art keywords: cancer; compositions; treatment; methods
Prior art date: 2009-03-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP10756546A

Other languages

German (de)

English (en)

Other versions

EP2411031A2 (fr

Inventor

Isaac Cohen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bionovo Inc

Original Assignee

Bionovo Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-24

Filing date

2010-03-01

Publication date

2012-08-01

2009-09-03 Priority claimed from US12/553,878 external-priority patent/US20100069480A1/en

2010-03-01 Application filed by Bionovo Inc filed Critical Bionovo Inc

2012-02-01 Publication of EP2411031A2 publication Critical patent/EP2411031A2/fr

2012-08-01 Publication of EP2411031A4 publication Critical patent/EP2411031A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP10756546A 2009-03-24 2010-03-01 Méthodes et compositions pour le traitement du cancer Withdrawn EP2411031A4 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US16298809P	2009-03-24	2009-03-24
US17263909P	2009-04-24	2009-04-24
US12/553,878 US20100069480A1 (en)	2008-09-03	2009-09-03	Methods and compositions for the treatment of cancer
PCT/US2010/025801 WO2010110993A2 (fr)	2009-03-24	2010-03-01	Méthodes et compositions pour le traitement du cancer

Publications (2)

Publication Number	Publication Date
EP2411031A2 EP2411031A2 (fr)	2012-02-01
EP2411031A4 true EP2411031A4 (fr)	2012-08-01

Family

ID=42781750

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP10756546A Withdrawn EP2411031A4 (fr)	2009-03-24	2010-03-01	Méthodes et compositions pour le traitement du cancer

Country Status (5)

Country	Link
EP (1)	EP2411031A4 (fr)
JP (1)	JP2012521424A (fr)
AU (1)	AU2010229167A1 (fr)
CA (1)	CA2756452A1 (fr)
WO (1)	WO2010110993A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103599237B (zh) *	2013-11-28	2015-06-03	姜永华	一种治疗瘀阻胃络型胃癌的中药及其制备方法
SG11201809988WA (en) *	2016-06-24	2019-01-30	Suntory Holdings Ltd	Composition for browning inhibition and use of same
CN110346494B (zh) *	2019-06-03	2021-09-28	云南农业大学	一种同时测定灯盏花中4种有效成分含量的方法
CN113018347B (zh) *	2021-03-01	2022-07-22	中国药科大学	一种中药提取物纳米粒及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010028187A2 (fr) *	2008-09-03	2010-03-11	Bionovo, Inc.	Procédés et compositions destinés au traitement du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1991006307A1 (fr) *	1989-11-03	1991-05-16	Sun Alexander S	Phytotherapie de malignite
US6294526B1 (en) *	1998-02-06	2001-09-25	Alps Pharmaceutical Ind. Co., Ltd.	Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
US7700136B2 (en) *	2005-11-14	2010-04-20	Bionovo, Inc.	Scutellaria barbata extract for the treatment of cancer

2010
- 2010-03-01 CA CA2756452A patent/CA2756452A1/fr not_active Abandoned
- 2010-03-01 WO PCT/US2010/025801 patent/WO2010110993A2/fr active Application Filing
- 2010-03-01 AU AU2010229167A patent/AU2010229167A1/en not_active Abandoned
- 2010-03-01 JP JP2012502070A patent/JP2012521424A/ja active Pending
- 2010-03-01 EP EP10756546A patent/EP2411031A4/fr not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2010028187A2 (fr) *	2008-09-03	2010-03-11	Bionovo, Inc.	Procédés et compositions destinés au traitement du cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HOPE RUGO ET AL: "Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer", BREAST CANCER RESEARCH AND TREATMENT, SPRINGER, NEW YORK, NY, vol. 105, no. 1, 1 September 2007 (2007-09-01), USA, pages 17 - 28, XP002620818, ISSN: 0167-6806, DOI: 10.1007/S10549-006-9430-6 *

Also Published As

Publication number	Publication date
EP2411031A2 (fr)	2012-02-01
AU2010229167A1 (en)	2011-10-20
CA2756452A1 (fr)	2010-09-30
WO2010110993A2 (fr)	2010-09-30
WO2010110993A3 (fr)	2011-01-13
JP2012521424A (ja)	2012-09-13

Publication	Publication Date	Title
IL267342A (en)	2019-08-29	Antibodies and preparations containing them for the treatment of cancer
IL225471A0 (en)	2013-06-27	Preparations and methods for the prevention and treatment of cancer
HK1159498A1 (en)	2012-08-03	Methods and compositions for the treatment of cancer
IL218987A0 (en)	2012-06-28	Methods and compositions for treating cancer
HK1226108A1 (zh)	2017-09-22	用於癌症治療的診斷方法和組合物
IL251083A0 (en)	2017-04-30	Compounds and preparations for the treatment of cancer
ZA201105472B (en)	2012-10-31	Methods and compositions for diagnosis and treatment of cancer
HK1166305A1 (zh)	2012-10-26	用於治療炎症的組合物及方法
EP2340027A4 (fr)	2012-04-04	Procédés et compositions destinés au traitement du cancer
IL214349A0 (en)	2011-09-27	Compositions and methods for the treatment of cancer
ZA201107879B (en)	2012-07-25	Composition for the treatment of prostate cancer
EP2429584A4 (fr)	2013-02-20	Procédés et compositions de traitement
IL240560A0 (en)	2015-09-24	Preparations and methods for tumor diagnosis and treatment
EP2411031A4 (fr)	2012-08-01	Méthodes et compositions pour le traitement du cancer
GB0808326D0 (en)	2008-06-18	Compositions and methods for the treatment of fybromyalgia

Legal Events

Date	Code	Title	Description
2011-12-30	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2012-02-01	17P	Request for examination filed	Effective date: 20111021
2012-02-01	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
2012-06-27	DAX	Request for extension of the european patent (deleted)
2012-08-01	A4	Supplementary search report drawn up and despatched	Effective date: 20120703
2012-08-01	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 36/534 20060101AFI20120627BHEP Ipc: A61P 35/00 20060101ALI20120627BHEP Ipc: A61K 31/352 20060101ALI20120627BHEP Ipc: A61K 31/37 20060101ALI20120627BHEP
2013-07-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-08-07	18D	Application deemed to be withdrawn	Effective date: 20130131